TY -非盟的吴Yi-Syuan AU - Wang Wei-Yun AU - Chan Ta-Chien盟——赵Yu-Lung AU - Lin Hung-Che AU - Chang Yu-Tien盟——吴Hao-Yi盟——刘,慈济盟,壮族Yu-Cheng盟——吴Jonan AU - Chang,文言文盟——太阳,Chien-An AU - Lin Meng-Chiung盟——曾文森特•S AU -胡Je-Ming AU - Li Yuan-Kuei盟——萧Po-Jen AU - Chen Chao-Wen盟——花王,Hao-Yun AU -李,Chia-Cheng盟,谢长廷Chung-Bao AU - Wang Chih-Hung盟——楚,Chi-Ming PY - 2022 DA - 2022/3/22 TI -任天堂Ring Fit冒险运动游戏对新冠肺炎大流行期间参与远程学习的大学生跑步完成时间和心理因素的影响随机对照试验乔-严肃游戏JMIR SP - e35040六世- 10 - 1 KW - exergaming KW -心脏力量指数KW -运行KW -身体活动KW -睡眠质量KW -情绪障碍KW -数字医疗KW -身体健康KW -任天堂环适合冒险KW - COVID-19流行AB -背景:COVID-19爆发不仅改变了人们的生活方式在全球范围内,而且还导致了其他挑战,如隔离的要求时期和远程学习。此外，人们无法冒险外出锻炼，导致运动减少，因此，在家锻炼的需求增加了。目的:本研究旨在探讨任天堂Ring Fit Adventure (RFA)干预与跑步时间、心力指数(CFI)、睡眠质量(中文版匹兹堡睡眠质量指数评分)和情绪障碍(5项简要症状评分量表评分)改善之间的关系。方法:这是一项随机前瞻性研究，包括80名学生，他们被要求在干预前后完成1600米的户外跑步，完成时间以秒为单位记录。他们还被要求填写一份生活方式问卷。在研究过程中，40名参与者(16名男性，24名女性，平均年龄23.75岁)被分配到RFA组，并要求在4周内每周锻炼3次30分钟(在冒险模式下)。运动强度是根据虚拟教练在第一场比赛中给出的指示设置的。其余40名参与者(男性30名，女性10名，平均年龄22.65岁)被分配到对照组，并在研究期间保持正常的生活习惯。 Results: The study was completed by 80 participants aged 20 to 36 years (mean 23.20, SD 2.96 years). The results showed that the running time in the RFA group was significantly reduced. After 4 weeks of physical training, it took females in the RFA group 19.79 seconds (P=.03) and males 22.56 seconds (P=.03) less than the baseline to complete the 1600-meter run. In contrast, there were no significant differences in the performance of the control group in the run before and after the fourth week of intervention. In terms of mood disorders, the average score of the RFA group increased from 1.81 to 3.31 for males (difference=1.50, P=.04) and from 3.17 to 4.54 for females (difference=1.38, P=.06). In addition, no significant differences between the RFA and control groups were observed for the CFI peak acceleration (CFIPA)_walk, CFIPA_run, or sleep quality. Conclusions: RFA could either maintain or improve an individual’s physical fitness, thereby providing a good solution for people involved in distance learning or those who have not exercised for an extended period. Trial Registration: ClinicalTrials.gov NCT05227040; https://clinicaltrials.gov/ct2/show/NCT05227040 SN - 2291-9279 UR - https://games.www.mybigtv.com/2022/1/e35040 UR - https://doi.org/10.2196/35040 UR - http://www.ncbi.nlm.nih.gov/pubmed/35315780 DO - 10.2196/35040 ID - info:doi/10.2196/35040 ER -